FDA Approves Expanded Indication of Mycamine (micafungin for injection) for the Treatment of Invasive Candidiasis in Pediatric Patients Less Than 4 Months of Age

FDA News, New FDA Approvals
January 8, 2020
A+ A-
Email Print

Article Link: FDA Approves Expanded Indication of Mycamine (micafungin for injection) for the Treatment of Invasive Candidiasis in Pediatric Patients Less Than 4 Months of Age

NORTHBROOK, Ill., Jan. 8, 2020 /PRNewswire/ — Astellas Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for Mycamine (micafungin for injection) in support of the…

Source: FDA New Drug Approvals

Posted by

Newer Post
Older Post